PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review

  • ID: 4278750
  • SWOT Analysis
  • 45 pages
  • GlobalData
  • PTC Therapeutics
1 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Acceleron Pharma Inc
  • Xencor Inc
  • MORE
PTC Therapeutics Inc (PTCT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief Summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

PTC Therapeutics Inc (PTC Therapeutics) discovers, develops, and commercializes orally active small molecule therapeutics that target post transcriptional control. The company's pipeline products include an orally administered small-molecule targeted at genetic disorders due to a nonsense mutation; an orally active small molecule to reduce the function, activity and amount of BMI1; and an investigational oral therapeutic used for the treatment of spinal muscular atrophy. PTC Therapeutics' ataluren is in phase 3 for the treatment of nonsense mutation duchenne muscular dystrophy.The company works in collaboration with various biotechnology and pharmaceutical companies for advancing its pipeline candidates. PTC Therapeutics is headquartered in South Plainfield, New Jersey, the US.

PTC Therapeutics Inc Key Recent Developments

Jun 05,2017: PTC Therapeutics Announces Executive Promotions
May 08,2017: PTC Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 10,2017: PTC Therapeutics Announces Departure of Chief Financial Officer, Shane Kovacs
Mar 16,2017: PTC Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Feb 08,2017: PTC Therapeutics Announces Third Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Abbott Laboratories
  • Acceleron Pharma Inc
  • Xencor Inc
  • MORE
Section 1 - About the Company
PTC Therapeutics Inc - Key Facts
PTC Therapeutics Inc - Key Employees
PTC Therapeutics Inc - Key Employee Biographies
PTC Therapeutics Inc - Major Products and Services
PTC Therapeutics Inc - History
PTC Therapeutics Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
PTC Therapeutics Inc - Business Description
PTC Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
PTC Therapeutics Inc - Strengths
PTC Therapeutics Inc - Weaknesses
PTC Therapeutics Inc - Opportunities
PTC Therapeutics Inc - Threats
PTC Therapeutics Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
PTC Therapeutics Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
Jun 05, 2017: PTC Therapeutics Announces Executive Promotions
May 08, 2017: PTC Therapeutics Reports First Quarter 2017 Financial Results and Provides Corporate Update
Apr 10, 2017: PTC Therapeutics Announces Departure of Chief Financial Officer, Shane Kovacs
Mar 16, 2017: PTC Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
Feb 08, 2017: PTC Therapeutics Announces Third Annual STRIVE Grant Award Program for Duchenne Muscular Dystrophy
Jan 09, 2017: PTC Therapeutics Provides Corporate Update and Outlines 2017 Strategic Priorities to Maximize the Global Value of Translarna and Advance its Innovative Pipeline
Nov 02, 2016: PTC Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update
Sep 12, 2016: PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Aug 04, 2016: PTC Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update
Jun 13, 2016: PTC Therapeutics Appoints Dawn Svoronos to Board of Directors

Section 6 - Appendix
Methodology
Ratio Definitions
About
Contact
Disclaimer

List of Tables
PTC Therapeutics Inc, Key Facts
PTC Therapeutics Inc, Key Employees
PTC Therapeutics Inc, Key Employee Biographies
PTC Therapeutics Inc, Major Products and Services
PTC Therapeutics Inc, History
PTC Therapeutics Inc, Other Locations
PTC Therapeutics Inc, Subsidiaries
PTC Therapeutics Inc, Key Competitors
PTC Therapeutics Inc, Ratios based on current share price
PTC Therapeutics Inc, Annual Ratios
PTC Therapeutics Inc, Annual Ratios (Cont...1)
PTC Therapeutics Inc, Annual Ratios (Cont...2)
PTC Therapeutics Inc, Interim Ratios
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
PTC Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
PTC Therapeutics Inc, Performance Chart (2012 - 2016)
PTC Therapeutics Inc, Ratio Charts
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
PTC Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Xencor Inc
  • Acceleron Pharma Inc
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll